Continuous renal replacement therapy sales will expand through 2036, with consumables at 53.0% of product type demand and renal at 70.0% of therapy sales in 2026. The market was valued at USD 1.4 billion in 2025 and is forecast to record an 8.1% CAGR between 2026 and 2036.